Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001908785 | SCV002172400 | pathogenic | DiGeorge syndrome | 2021-04-16 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has been observed in individual(s) with clinical features of DiGeorge/velocardiofacial syndrome (Invitae). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Glu258Profs*60) in the TBX1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TBX1 are known to be pathogenic (PMID: 25860641, 29500247). |